BioElectronics Corporation BIEL
OTC PK
| 12/31/2021 | 09/30/2021 | 06/30/2021 | 03/31/2021 | ||
|---|---|---|---|---|---|
| Net Income | -17.48% | 106.70% | 85.80% | 64.72% | |
| Total Depreciation and Amortization | -- | -- | -- | -- | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 36.81% | -172.34% | -34.91% | 235.21% | |
| Change in Net Operating Assets | 96.97% | -127.93% | 38.88% | -189.71% | |
| Cash from Operations | 157.10% | -1,485.86% | 96.60% | -51.98% | |
| Capital Expenditure | -- | -- | -- | -- | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -- | -- | -- | |
| Cash from Investing | -- | -- | -- | -- | |
| Total Debt Issued | -40.55% | 11.11% | -53.37% | -15.48% | |
| Total Debt Repaid | -2,404.65% | 91.71% | 80.11% | 66.97% | |
| Issuance of Common Stock | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | 14.58% | -- | -- | -- | |
| Cash from Financing | -167.63% | 3,957.14% | -73.08% | 14.46% | |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -183.09% | -285.04% | 3,811.76% | -264.96% | |